Previously treated cases tested for RR-/MDR-TB in Europe (WHO region)
Europe (WHO region): Previously treated cases tested for RR-/MDR-TB was 90.0% in 2024. ◆ Volatile
Latest (2024)
90.0%
Change on year
down 6.2%
Rank
2nd
of 11 groups
All-time high
96.0%
in 2023
All-time low
8.2%
in 2005
Years of data
20
2005–2024
Previously treated cases tested for RR-/MDR-TB in Europe (WHO region), 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Europe (WHO region) stood at 90.0%.
Compared with earlier readings it is down 6.2% on the previous year and up 73.1% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Europe (WHO region) peaked at 96.0% in 2023 and was at its lowest, 8.2%, in 2005.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Europe (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 8.2% | — |
| 2006 | 20.0% | +143.9% |
| 2007 | 15.0% | -25.0% |
| 2008 | 16.0% | +6.7% |
| 2009 | 42.0% | +162.5% |
| 2010 | 41.0% | -2.4% |
| 2011 | 35.0% | -14.6% |
| 2012 | 44.0% | +25.7% |
| 2013 | 41.0% | -6.8% |
| 2014 | 52.0% | +26.8% |
| 2015 | 50.0% | -3.8% |
| 2016 | 64.0% | +28.0% |
| 2017 | 64.0% | +0.0% |
| 2018 | 93.0% | +45.3% |
| 2019 | 93.0% | +0.0% |
| 2020 | 94.0% | +1.1% |
| 2021 | 95.0% | +1.1% |
| 2022 | 94.0% | -1.1% |
| 2023 | 96.0% | +2.1% |
| 2024 | 90.0% | -6.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 20.2% | 8.2% | 42.0% | 5 |
| 2010s | 57.7% | 35.0% | 93.0% | 10 |
| 2020s | 93.8% | 90.0% | 96.0% | 5 |
Countries ranked near Europe (WHO region)
- 1 Côte d'Ivoire 100.0% compare
- 1 Zambia 100.0% compare
- 1 Lithuania 100.0% compare
- 1 Slovenia 100.0% compare
- 1 Sri Lanka 100.0% compare
- 1 Bangladesh 100.0% compare
- 1 Fiji 100.0% compare
- 1 Norway 100.0% compare
- 1 Kuwait 100.0% compare
- 1 Luxembourg 100.0% compare
- 1 Armenia 100.0% compare
- 1 Gambia 100.0% compare
- 1 Ghana 100.0% compare
- 1 Yemen 100.0% compare
- 1 Oman 100.0% compare
- 1 Brunei Darussalam 100.0% compare
- 1 Togo 100.0% compare
- 1 Israel 100.0% compare
- 1 Cameroon 100.0% compare
- 1 Jamaica 100.0% compare
- 1 Eritrea 100.0% compare
- 1 Cyprus 100.0% compare
- 1 Montenegro 100.0% compare
- 1 Sao Tome and Principe 100.0% compare
- 1 Viet Nam 100.0% compare
- 1 Belize 100.0% compare
- 1 Marshall Islands 100.0% compare
- 1 Republic of Moldova 100.0% compare
- 1 Comoros 100.0% compare
- 1 Kazakhstan 100.0% compare
- 1 Lao People's Democratic Republic 100.0% compare
- 1 Antigua and Barbuda 100.0% compare
- 1 Afghanistan 100.0% compare
- 1 Benin 100.0% compare
- 1 Jordan 100.0% compare
- 1 Puerto Rico 100.0% compare
- 1 Saint Vincent and the Grenadines 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Congo 100.0% compare
- 1 Eswatini 100.0% compare
- 1 Micronesia, Federated States of 100.0% compare
- 1 Iceland 100.0% compare
- 1 Belarus 100.0% compare
- 1 Albania 100.0% compare
- 1 Mauritania 100.0% compare
- 1 Bhutan 100.0% compare
- 1 Tuvalu 100.0% compare
- 1 Malta 100.0% compare
- 1 Iraq 100.0% compare
- 1 Republic of Korea 100.0% compare
- 1 Papua New Guinea 100.0% compare
- 1 Bahamas 100.0% compare
- 1 Zimbabwe 100.0% compare
- 1 Andorra 100.0% compare
- 1 Turkmenistan 100.0% compare
More health data for Europe (WHO region)
- Total tetanus - number of reported cases, gaps filled 85 (2025)
- Diphtheria - number of reported cases, gaps filled 199 (2025)
- Measles - number of reported cases, gaps filled 38,686 (2025)
- Pertussis - number of reported cases, gaps filled 52,021 (2025)
- Measles - number of reported cases, annual growth rate -74.39 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -82.58 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate -33.59 % change on previous year (2025)
- Measles - number of reported cases 38,686 (2025)
- Pertussis - number of reported cases 52,021 (2025)
- Total tetanus - number of reported cases 85 (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Europe (WHO region)?
- Previously treated cases tested for rr-/mdr-tb in Europe (WHO region) was 90.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Europe (WHO region)?
- The highest recorded value was 96.0% in 2023.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Europe (WHO region)?
- The lowest recorded value was 8.2% in 2005.
- How does Europe (WHO region) rank for previously treated cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 2nd out of 11 groups with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Europe (WHO region)?
- Over the last ten years it is up 73.1%. The long-run trend across the full record is volatile.
- Where does this Europe (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).